The largest database of trusted experimental protocols

Superdex 200 10 300 gl gel filtration column

Manufactured by GE Healthcare
Sourced in United States, Sweden, United Kingdom

The Superdex 200 10/300 GL gel filtration column is designed for the separation and purification of proteins, peptides, and other biomolecules. It is a size-exclusion chromatography column that separates molecules based on their size and shape. The column is packed with a highly cross-linked agarose-dextran matrix, which provides a wide separation range and high resolution. The Superdex 200 10/300 GL column has a bed volume of 24 ml and can be used for a wide variety of applications in the field of biochemistry and biotechnology.

Automatically generated - may contain errors

24 protocols using superdex 200 10 300 gl gel filtration column

1

SEC-MALS Analysis of MexT Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sizes of FL MexT and MexT RD were assayed using SEC-MALS. A high-performance liquid chromatography pump (Agilent, USA) was connected to a Superdex-200 10/300 GL gel filtration column (GE Healthcare) and a MALS instrument (Wyatt Dawn Heleos, USA). The size-exclusion chromatography column was pre-equilibrated with buffer comprising 20 mM Tris-HCl (pH 8.5), 500 mM NaCl, and 2 mM 2-mercaptoethanol for FL MexT; and 20 mM Tris-HCl (pH 8.5), 300 mM NaCl, and 2 mM 2-mercaptoethanol for MexT RD. Bovine serum albumin (2 mg/ml) was used as the standard. MexT RD and FL MexT samples (2 mg/ml) were injected onto the column and eluted at a flow rate of 0.2 ml/min. The datasets were evaluated using the Debye model for fitting static light-scattering data, and refractive index peaks were presented in EASI graphs created using Astra V software (Wyatt Dawn Heleos).
+ Open protocol
+ Expand
2

HLA-A*0201 Tetramer Preparation for Peptide Presentation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human leukocyte antigen-A*0201-restricted tetramers with peptide NY-ESO-1157−165: SLLMWITQC or HPV-E629−38: TIHDIILECV were prepared as previously described (48 (link)). Briefly, the extracellular domain of HLA-A*0201 (1-276) was modified by the addition of a substrate sequence for the biotinylation enzyme BirA at the C-terminus of the α3 domain. The modified HLA-A2 and β2-microglobulin were expressed in Escherichia coli and refolded in the presence of peptides. In vitro-renatured peptide/HLA-A2 complexes were then purified and biotinylated by incubation with D-biotin, ATP, and the biotin protein ligase BirA (Avidity, Aurora, Colorado) at 4°C for 12 h. The samples were further purified using a Superdex 200 10/300 GL gel filtration column (GE Healthcare, Chicago, Illinois). Finally, the tetramers were formed by mixing with PE-streptavidin (Sigma-Aldrich, Saint Louis, Missouri) and stored at 4°C in PBS containing 0.5 mM EDTA, 0.2% BSA, 10 mM Tris-HCI (pH 8.0), 150 mM NaCI, and 0.09% NaN3.
+ Open protocol
+ Expand
3

Structural Determination of PrgB Dimer

Check if the same lab product or an alternative is used in the 5 most similar protocols
PrgB188–1233 dimer fractions were thawed on ice and loaded on a Superdex 200 10/300 GL gel filtration column (GE Healthcare) equilibrated in 20 mM HEPES/NaOH pH 7.0 and 150 mM NaCl. Protein peak fractions, corresponding to the dimer, were diluted to 0.1–0.3 mg/ml and for the DNA-bound structures 120-bp ssDNA (Table 1) was added in 1:1.2 molar ratio (protein:DNA) and samples were incubated for 15 min on ice. For both apo and DNA-bound samples, 4 μl of sample was applied to glow discharged Quantifoil 300 mesh 1.2/1.3 (Quantifoil) grids at 4°C and 90–100% humidity, blotted for 1 s with blot force −5, and plunge-frozen in liquid ethane using a Vitrobot Mark IV (Thermo Fisher Scientific).
+ Open protocol
+ Expand
4

Gel Filtration Purification of TRX-T-TXNIP

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Superdex 200 10/300 GL gel filtration column (GE Healthcare) installed on an AKTA purifier FPLC system (GE Healthcare) was equilibrated with 50 mM Tris-HCl (pH 8.0), 500 mM NaCl and 10% glycerol at a flow rate of 0.4 ml min−1 at room temperature. The purified TRX–T–TXNIP complex and its mutants were injected onto the column. Ovalbumin was used as the molecular weight standard.
+ Open protocol
+ Expand
5

Purification and Characterization of IMP3 RRM12

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified IMP3 RRM12 (in buffer 20 mM Tris pH 7.5, 150 mM NaCl, 1 mM DTT) was concentrated to 5 mg ml−1 and loaded to a Superdex 200 10/300 GL gel-filtration column (GE Healthcare) equilibrated in 20 mM Tris pH 7.5, 200 mM NaCl, 0.02% w/v NaN3, and 1 mM DTT. Light scattering was recorded with an in-line miniDAWN TREOS three angle light scattering detector (Wyatt Technology), and protein concentration was detected using an in-line Optilab T-rEX refractive index detector (Wyatt Technology). The molecular mass of IMP3 RRM12 was calculated using ASTRA 6 software (Wyatt Technology).
+ Open protocol
+ Expand
6

Characterizing sDM-Fab Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Experiments with sDM immobilized were performed at 25 °C, using a Biacore 3000 (GE Healthcare). Experiments with Fab immobilized were performed using a Biacore T200 (GE Healthcare). Stock solutions of sDM and b12 Fab were monodisperse, after purification on a Superdex 200 10/300 GL gel filtration column (GE Healthcare). sDM-biotin was immobilized to ~1000 RUs onto a streptavidin-coated (SA) sensor (GE Healthcare) by injection of ~10 nM at 10 μl/min in HEPES-buffered saline with surfactant P20 (HBS-P). b12 Fab was immobilized to ~4000 RUs, by amine chemistry, onto a CM5 sensor (GE Healthcare), injecting at 5 μl/min, 2.5 μg/ml, in pH 5, 10 mM sodium acetate buffer. sDM/Fab interaction was measured in 20mM MES (pH 5.7 or pH 6.7), 100mM NaCl, 0.002% p20). Where indicated, NaCl was elevated to 150 mM. Varying concentrations of sDM, b12 Fab or 40 μM Fc were injected (20 μl/min) across a reference flow cell and the flow cell with immobilized ligand. To determine the apparent KD, the reference signal was subtracted at each time point, and equilibrium data were fit to the “one site-specific” mass action model using Prism 6 software.
+ Open protocol
+ Expand
7

Sizing of (+)-Ligand Substrate by SEC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Size-exclusion chromatography (SEC) was conducted using an Äkta FPLC system (Amersham Biosciences, Uppsala, Sweden) equipped with a Superdex-200 10/300 GL gel filtration column (GE Healthcare Life Sciences); 300 μL of 100 μM (+)-LS was loaded onto the column that was equilibrated in 50 mM Tris (pH 8), 100 mM NaCl, and 10% glycerol at 4 °C. The flow was maintained at a constant rate of 0.5 mL/min. The void volume was measured at 8.3 mL by eluting blue dextran as a high-molecular weight standard (MW ~ 2000 kDa). The total internal column volume was measured at 21.19 mL with vitamin B12 as a low-molecular weight standard (MW = 1.35 kDa). These and other well-resolved molecular weight standards were used to derive a standard curve that allowed accurate estimation of the molecular weight of eluted (+)-LS.
+ Open protocol
+ Expand
8

Protein Fractionation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
After treatments, PC3 cells were collected and homogenized in homogenization buffer (40 mM Tris-HCl pH 7.5, 150 mM NaCl and a protease inhibitor mixture from Roche Applied Science) by repeatedly passing (15 times) through a 1 ml syringe with a 23-gauge needle. The homogenate was centrifuged at 13,000g for 30 min. The resulting supernatants (2.0 mg protein in 500 μl) were then applied to a Superdex 200 10/300 GL gel filtration column (GE Healthcare) and eluted at a flow rate of 0.5 ml min−1 with 40 mM Tris-HCl, pH 7.5 and 150 mM NaCl. Fractions of 500 μl were collected and 20 μl from each fraction was analysed by western blot.
+ Open protocol
+ Expand
9

Peptide-MHC Tetramer Preparation and Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
H-2Db-restricted tetramers of peptides NP366−374 and PA224−233 and HLA-A*24-restricted tetramers of peptides H1-P25 and H7-P25 were prepared as previously described (30 (link)). Preparation and staining of H-2Db-restricted tetramers were performed as follows. Briefly, to produce biotinylated peptide-MHC protein, H-2Db was modified by the addition of a substrate sequence for biotinylating enzyme BirA at the C terminus of the α3 domain. In vitro-renatured H-2Db/peptide complexes were then purified and biotinylated by incubation with d-biotin, ATP, and the biotin protein ligase BirA (Avidity) at 4°C for 12 h. The biotinylated H-2Db was further purified using a Superdex 200 10/300 GL gel-filtration column (GE Healthcare) to remove excess biotin and then mixed with PE-streptavidin (Sigma). Cells from the subjects were stained with PE-tetramer, FITC-conjugated anti-CD3 antibody, and PerCP-cy5.5 anti-CD8 antibody. All samples were analyzed with a FACSCalibur flow cytometer (Becton, Dickinson) after staining.
+ Open protocol
+ Expand
10

Expressing and Purifying IEkMCC Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid construct for expressing the extracellular domain of IEk with covalently linked MCC peptide was a gift from John Kappler (National Jewish Health). For conjugation with polymers, the construct was modified by PCR to add a cysteine at the C-terminus of the β chain. Baculoviruses were generated with the construct and BaculoGold Linearized baculovirus DNA (BD Biosciences, San Diego, CA) in Sf9 insect cells (Invitrogen, Calsbad, CA). High titer stocks of cloned recombinant baculovirus were used to infect Hi5 insect cells (Invitrogen, Calsbad, CA) cultured in spinner flasks. IEkMCC protein was purified from the supernatant of infected Hi5 cell cultures using an affinity chromatography column conjugated with 14-4-4s antibody. The protein was further purified using a Superdex 200 10/300 GL gel filtration column (GE Healthcare, Piscataway, NJ) before conjugating with PEG linkers. The design and production of IEkMCC with a C-terminal AviTag was described previously [15] (link). The protein was biotinylated at the lysine residue of the AviTag using BirA enzyme as described previously [15] (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!